Publications

The Affordability of Lecanemab, an Amyloid-Targeting Therapy for Alzheimer's Disease: an Eadc-Ec Viewpoint

AuthID
P-00Y-P67

Author(s)

Jonsson, L

Wimo, A

Handels, R

Johansson, G

Boada, M

Engelborghs, S

Frolich, L

Jessen, F

Kehoe, PG

Kramberger, M

de Mendon, A

Ousset, PJ

Scarmeas, N

Visser, PJ

Waldemar, G

Winblad, B

Document Type

Article

Year published

2023

Published

in LANCET REGIONAL HEALTH-EUROPE, ISSN: 2666-7762

Volume: 29

Indexing

Wos^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.lanepe.2023.100657

Pubmed: 37251789

Wos: WOS:001013629500001

Source Identifiers

ISSN: 2666-7762

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

The Affordability of Lecanemab, an Amyloid-Targeting Therapy for Alzheimer's Disease: an Eadc-Ec Viewpoint

Useful Links

Get Help

Federated Authentication (Click on the image)

The Affordability of Lecanemab, an Amyloid-Targeting Therapy for Alzheimer's Disease: an Eadc-Ec Viewpoint

Useful Links

Get Help